Dapagliflozin + Saxagliptin

Category: Diabetes

Dapagliflozin + Saxagliptin Overview

Dapagliflozin (INN,[2] USAN,[3] trade name Farxiga /frsi/ far-SEE-g in the U.S. and Forxiga in the EU and Russia) is a drug of the gliflozin class, used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca. Contents 1 Medical uses 2 Side effects 3 Mechanism of action 3.1 Selectivity 4 Research 5 References 6 External links Medical uses In July 2011 a U.S. Food and Drug Administration (FDA) endocrinologic...

Read more Dapagliflozin + Saxagliptin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dapagliflozin

Recent Dapagliflozin + Saxagliptin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (9 results)

• QTERN Dapagliflozin + Saxagliptin
• DAPAGLIFLOZIN 1 discussion
• DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE
• FARXIGA Dapagliflozin5 discussions
• KOMBIGLYZE XR Metformin Hydrochloride + Saxagliptin3 discussions
• METFORMIN HYDROCHLORIDE + SAXAGLIPTIN
• ONGLYZA Saxagliptin Hydrochloride1 discussion
• SAXAGLIPTIN HYDROCHLORIDE
• XIGDUO XR Dapagliflozin +metformin Hydrochloride

Related Dapagliflozin + Saxagliptin Topics: